These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 33866336)
41. Prognostic Performance of RECIP 1.0 Based on [ Hartrampf PE; Hüttmann T; Seitz AK; Kübler H; Serfling SE; Higuchi T; Schlötelburg W; Michalski K; Gafita A; Rowe SP; Pomper MG; Buck AK; Werner RA J Nucl Med; 2024 Apr; 65(4):560-565. PubMed ID: 38453363 [TBL] [Abstract][Full Text] [Related]
42. Assessment of the role of Ga-68 PSMA I&T PET/CT in response evaluation to docetaxel therapy in castration resistant prostate cancer patients. Özülker T; Özülker F Rev Esp Med Nucl Imagen Mol (Engl Ed); 2020; 39(5):292-298. PubMed ID: 32595026 [TBL] [Abstract][Full Text] [Related]
43. Detection Efficacy of Hybrid Einspieler I; Rauscher I; Düwel C; Krönke M; Rischpler C; Habl G; Dewes S; Ott A; Wester HJ; Schwaiger M; Maurer T; Eiber M J Nucl Med; 2017 Jul; 58(7):1081-1087. PubMed ID: 28209912 [TBL] [Abstract][Full Text] [Related]
44. Prediction of early biochemical response after 177Lu-PSMA radioligand therapy with 68Ga-PSMA PET, a different perspective with quantitative parameters. Aksu A; Vural Topuz Ö; Yilmaz B; Karahan Şen NP; Acar E; Çapa Kaya G Nucl Med Commun; 2022 Apr; 43(4):468-474. PubMed ID: 35045552 [TBL] [Abstract][Full Text] [Related]
46. Clinicopathological predictors of positive Aydin AM; Haberal B; Artykov M; Bilen CY; Yazici S Ann Nucl Med; 2019 May; 33(5):326-332. PubMed ID: 30778860 [TBL] [Abstract][Full Text] [Related]
47. Is there a utility of adding skeletal imaging to 68-Ga-prostate-specific membrane antigen-PET/computed tomography in initial staging of patients with high-risk prostate cancer? Raju S; Sharma A; Patel C; Sahoo R; Das CJ; Kumar S; Sharma A; Kumar R Nucl Med Commun; 2020 Nov; 41(11):1183-1188. PubMed ID: 32796451 [TBL] [Abstract][Full Text] [Related]
48. Head-to-head comparisons of [ Ke ZB; Chen SM; Chen JY; Chen SH; You Q; Sun JB; Xue YT; Sun XL; Wu XH; Zheng QS; Wei Y; Xue XY; Xu N Eur J Nucl Med Mol Imaging; 2023 Mar; 50(4):1240-1251. PubMed ID: 36416906 [TBL] [Abstract][Full Text] [Related]
49. Positron Emission Tomography/Computed Tomography with Gallium-68-labeled Prostate-specific Membrane Antigen Detects Relapse After Vascular-targeted Photodynamic Therapy in a Prostate Cancer Model. Alvim R; Nagar K; Das S; Lebdai S; Wong N; Somma A; Hughes C; Thomas J; Monette S; Scherz A; Kim K; Grimm J; Coleman JA Eur Urol Focus; 2021 Mar; 7(2):472-478. PubMed ID: 31227464 [TBL] [Abstract][Full Text] [Related]
50. The frequency of thyroid incidental findings and risk of malignancy detected by Gossili F; Petersen LJ; Zacho HD Hell J Nucl Med; 2020; 23(3):240-245. PubMed ID: 33306753 [TBL] [Abstract][Full Text] [Related]
51. Comparison of quantitative whole body PET parameters on [ Ayati N; McIntosh L; Buteau J; Alipour R; Pudis M; Daw N; Jackson P; Hofman MS Cancer Imaging; 2024 May; 24(1):57. PubMed ID: 38711135 [TBL] [Abstract][Full Text] [Related]
52. [ Xie Y; Li C; Zhang L; Zang S; Yu F; Wang S; Wang F Nan Fang Yi Ke Da Xue Xue Bao; 2022 Aug; 42(8):1143-1148. PubMed ID: 36073212 [TBL] [Abstract][Full Text] [Related]